Combination of reovirus (Pelareorep) and granulocyte-macrophage colony-stimulating factor (GM-CSF) alongside standard chemoradiotherapy and adjuvant chemotherapy (temozolomide) for patients with glioblastoma multiforme (GBM): Long term follow up results of the ReoGliophase Ibtrial

Short, Susan, Previously presented at the American Association for Cancer Research Annual Meeting 2022; April 8-13, 2022